This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2014 Jan;63(1):23-4.

doi: 10.1097/FJC.0000000000000024.

Atrial-selective antiarrhythmic activity by vernakalant fact or fiction?

Torsten Christ¹

Affiliations

PMID: 24084225
DOI: 10.1097/FJC.0000000000000024

Comment

Atrial-selective antiarrhythmic activity by vernakalant fact or fiction?

Torsten Christ. J Cardiovasc Pharmacol. 2014 Jan.

. 2014 Jan;63(1):23-4.

doi: 10.1097/FJC.0000000000000024.

Author

Torsten Christ¹

Affiliation

¹ Department of Experimental Pharmacology and Toxicology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

PMID: 24084225
DOI: 10.1097/FJC.0000000000000024

No abstract available

PubMed Disclaimer

Comment on

Electrophysiological and hemodynamic effects of vernakalant and flecainide during cardiac resynchronization in dyssynchronous canine hearts.
van Middendorp LB, Strik M, Houthuizen P, Kuiper M, Maessen JG, Auricchio A, Prinzen FW. van Middendorp LB, et al. J Cardiovasc Pharmacol. 2014 Jan;63(1):25-32. doi: 10.1097/FJC.0000000000000020. J Cardiovasc Pharmacol. 2014. PMID: 24084224

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Wolters Kluwer
Other Literature Sources
- scite Smart Citations